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Abstract
Background: Many patients who have been treated for breast cancer experience high levels of fear that the cancer
will return. The FORECAST pilot study showed that for a third of the patients, fears of cancer recurrence (FCR) increase
during radiotherapy treatment and that conversations with their therapeutic radiographer at the weekly review meetings
might help patients manage these concerns. This study aims to develop a communication skills training package (KEW,
for ‘Know’, ‘Encourage’ and ‘Warm-up’) for therapeutic radiographers based on the findings of the FORECAST pilot study
and on active input from patients and radiographers. This package will be piloted in a single centre to evaluate its
acceptability and to prepare for a multi-centre clinical trial.
Methods: The study consists of three phases. In the first phase, patient representatives and therapeutic radiographers
participate in Experience-Based Co-Design to identify ways to improve communication during the radiotherapy review.
In the second phase, various stakeholders, including members of the Society of Radiographers and of national patient
representation groups, are consulted to develop a storyboard for the production of the communication training package.
In the third phase, the acceptability and feasibility of the training is evaluated through observations, recruitment rates and
follow-up discussions; a fidelity measure is designed; and potential benefits are observed, with patients’ fear of cancer
recurrence (FCR7) as the primary outcome. Secondary outcomes include a short daily measure of recurrence (FCR3),
patients’ positive and negative affect (PANAS), perceived empathy from the radiographer (CARE), satisfaction with the
review meetings (RISS) and health-related quality of life (EQ-5D-3L).
Discussion: To date, there has been limited research on how communication between therapeutic radiographers and
patients during review appointments can help to manage patients’ recurrence fears during radiotherapy treatment. A
collaborative and participatory approach to the development of a communication skills training will ensure that it is
optimally targeted to the needs and preferences of both patients and radiographers. Targeting recurrence fears through
communication at this stage, when patients are still in regular contact with healthcare providers, has the potential to
reduce the need for complex interventions post-treatment.
Trial registration: NRES reference: 18/LO/0669. Clinicaltrial.gov ID: NCT03468881
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Background
Breast cancer is the most common cancer in the UK,
with 54,900 new cases every year [1]. Steadily improving
survival rates also mean that the number of people who
are breast cancer survivors is growing [2]. After treat-
ment has finished, patients’ physical and psychological
symptoms do not immediately end and survivors need
to be supported to cope with the consequences of their
treatment and with the concerns that they experience
[3]. Often, breast cancer survivors are most concerned
about the possibility of their cancer returning [4–6]: up
to 86% of all breast cancer survivors experience some
level of this fear, moderate levels are reported by 24 to
56%, and up to 14% of survivors experience high levels
of recurrence fears [7].
Fear of cancer recurrence (FCR) has been defined as
the ‘fear, worry, or concern relating to the possibility that
the cancer will come back or progress’ [8]. High levels of
FCR are associated with higher health costs [9] and have
been linked to health behaviour and psychological re-
sponses such as distress, depression and anxiety [7]. Due
to its high prevalence and serious consequences, it has
been advised to carry out routine assessment for FCR
following treatment [9]. To help patients who do experi-
ence clinical levels of recurrence fears, various psycho-
logical interventions have been developed, including
Conquer Fear [10], SWORD (‘Survivors’ Worries of Re-
current Disease’) [11] and the AFTER intervention [12].
However, ideally, patients would be supported in such
a way to minimise the development of these fears before
they rise to clinical levels, which was the focus of the
FORECAST pilot study [13]. The Lee-Jones model of
FCR describes that in addition to patients’ internal cues,
external cues such as communication with healthcare
providers can trigger an emotional and cognitive re-
sponse that result in patients’ personal perception of
recurrence [14]. A recent study also found empirical evi-
dence for the relation between such cues and FCR [15].
In addition, there is work that suggests that patients’
perceived quality of interactions during the diagnostic
consultation can indeed affect their FCR levels [16].
FORECAST analysed conversations between 89 patients
and their radiographers during the weekly review appoint-
ments and identified these sessions as a crucial target
point—it was seen that patients whose FCR trajectories
decreased during radiotherapy were more likely to men-
tion cancer directly at the review appointments, had lon-
ger consultations, and expressed twice as many emotional
concerns [17]. Furthermore, a significant relationship was
seen between patients FCR levels and closing down of
patients’ conversations in a clinical encounter during a
review appointment in the radiotherapy unit. Since radio-
therapy services for breast cancer patients often include a
review service [18], this could be an optimal moment to
address patients’ recurrence fears before they rise to exces-
sive levels. The outlined protocol describes the follow-up to
this study, FORECAST2 [19]. FORECAST2 builds upon
the findings of the pilot study to develop a communication
skills training package for therapeutic radiographers, to help
them respond to emotional concerns that are expressed by
patients at the review appointments. Theoretically, the
package will be modelled on an intervention for general
practitioners that successfully helped patients feel less
distressed and more satisfied with the consultation [20] to
target patient Knowledge, Encouragement to patients to
express concerns and Warm-Up to avoid sudden cutoffs at
the end of the conversations (KEW). In addition, patients
and therapeutic radiographers will be actively involved in
the development of the training package through Experi-
enced-Based Co-Design (EBCD), to encourage the ex-
change of experiences between patients and healthcare
providers and identify shared points for improvements
and solutions [21].
The aims of the study outlined in this protocol are (1)
to develop a communication skills training package for
therapeutic radiographers and (2) to pilot this package
in a single service. The evaluation will include the obser-
vation of potential benefits in practice, in particular the
effect of the package on patients’ development of FCR
trajectories. In addition, the single-service evaluation will
help to prepare for a formal randomised trial by evaluat-
ing the acceptability and feasibility of presentation to
staff and patients, completing electronic diary assess-
ment of recurrence fears, and the design of a fidelity
measure.
Methods/design
This study consists of three phases (Fig. 1): a co-design,
production and evaluation phase.
Phase 1—Co-design
The aim of the first phase is to identify shared issues in
communication during radiotherapy treatment with
breast cancer patients and therapeutic radiographers and
to work on solutions to help improve this communica-
tion. This exploratory phase of the study will be guided
by principles of EBCD [22] and will make use of a var-
iety of participatory methods, including card sorting to
identify priorities, brainstorming to generate ideas and
the emotional mapping exercise [23], in which patients
can identify and rank critical moments in their radio-
therapy treatment. Four patient representatives and
three therapeutic radiographers will be recruited at a
specialist breast cancer centre in Scotland through the
investigators’ networks, based on willingness to partici-
pate. Eligible patient representatives are female, are over
18 years of age and have received radiotherapy to treat
their breast cancer.
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Phase 1 will start with introductory individual inter-
views with the patients and radiographers to identify
their experiences with the radiotherapy service and to
discuss improving communication (Table 1). The patient
interviews will be filmed, and a short video will be edited
to capture patient experience. This film will be validated
at a patient feedback event and later shown at a joint
patient-staff event as the starting point to share experi-
ences and agree on areas for improvement. Prior to the
joint event, radiographers will also have a feedback event
to validate findings from the interviews and to distin-
guish between issues to be addressed internally and
those to be discussed in the co-design process. After the
video is discussed at the joint patient-staff event, a
co-design session follows to work on solutions to the is-
sues that are raised. All sessions that are not filmed will
be audiotaped and can be transcribed to identify themes
in participants’ responses using a thematic framework
approach; emphasis will be on summarising and validat-
ing participants’ input during the sessions.
Phase 2—Production
The second phase of the outlined study works towards
the production of a video and training manual for the
communication training package. Based on the findings
of phase 1, evidence on successful strategies to improve
patients’ satisfaction with consultations [20] and on cor-
relations between patient-provider interactions during
review appointments and patients’ levels of FCR [17],
the modules that will be covered in the training work-
shop will be determined and a storyboard will be created
for the production of the training package. Examples of
the types of communication interventions that are likely
to be covered include open-ended general questions on
how the patient is managing and how they are feeling, to
listen to enquiries and provided additional information
(Knowledge), to acknowledge emotional cues and pre-
vent closing the patient down (Emotion) and to give a
positive finishing statement on closing the review session
(Warmth). The storyboard will be evaluated and ad-
justed in an iterative process with consultative input
from a variety of stakeholders.
Participants in this phase will include up to ten mem-
bers of patient representation groups throughout the
country and a radiotherapy stakeholder group with eight
members of the Society of Radiographers. Participants
will be recruited through the networks of the authors
based on willingness to participate. Inclusion criteria for
Fig. 1 Flowchart of outlined study, consisting of three consecutive phases
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patient participants are as described for phase 1 of the
study. Based on the logistical feasibility, consultative in-
put will be invited either through face-to-face interviews
or through email, using the Feedback Capture Grid
(Interaction Design Foundation). Face-to-face sessions
will be audiotaped, and themes in participants’ responses
will be explored as described for phase 1.
Phase 3—Evaluation
The aim of the third phase of the study, an observational
cohort study, is to evaluate the communication training
package in a specialist breast cancer centre in Scotland.
All women with breast cancer who undergo radiotherapy
treatment at this centre are seen at the weekly review
appointments (usually two to three times and up to four
to five for patients with ductal carcinoma in situ), as
follow-up appointments and GP letters are generated at
these clinics. Therapeutic radiographers who are willing
to participate will follow an in-person session with a
trained facilitator using the communication skills train-
ing package. Written materials will be available with ex-
amples, and workshop experiential sessions will be
provided, as well as supervision by a clinical psychologist
and communication trainer.
The radiographers will screen for patient eligibility (i.e.
adult, English-speaking, female invasive breast cancer
patients about to receive radiotherapy as primary or
adjuvant treatment) and invite patients to participate in
the study (t−1) (Fig. 2). Patients who are interested to
participate are referred to the investigator who will pro-
vide them with more information. Written informed
consent is obtained from those who are willing to par-
ticipate. Around the radiotherapy planning session (t1),
patients are asked to provide their demographic details
and to fill out the seven-item Fear of Cancer Recurrence
(FCR7) measure and Positive And Negative Affect Scale
(PANAS) (Table 2). During radiotherapy treatment, the
regular weekly review consultations between the patient
and therapeutic radiographer will be audiotaped (t2).
During these 3 to 4 weeks, patients fill out FCR7 on a
weekly basis and the three-item Fear of Cancer Recur-
rence (FCR3) on a daily basis, either in the form of a
printed diary or in a smartphone application according
to patient preference. At the end of radiotherapy (t3), pa-
tients fill out the FCR7 and PANAS again and evaluate
their experience with the consultations using the Con-
sultation and Relational Empathy (CARE) measure and
the Radiotherapy Interview Satisfaction Scale (RISS), a
version of the Medical Interview Satisfaction Scale modi-
fied to better fit the radiotherapy consultations. Six to
eight weeks after the end of their treatment (t4), patients
will receive a telephone call from the investigator to
measure their recurrence fears (FCR7) one last time and
their health status, using the EQ-5D-3L.
In addition to the observation of potential benefits relat-
ing to patient outcomes, the acceptability and feasibility of
the communication training package is evaluated through
analysis of the audiotaped sessions and follow-up discus-
sions with patients and radiographers. A 10% sample of
patients will be invited to give free response comments
from semi-structured interviews to their experience of the
review consultations. These patients will be prompted to
state the acceptability (rating on a 1 to 5 ordinal scale
from ‘not acceptable’ to ‘completely acceptable’) of the
major elements of the intervention, e.g. staff instructed to
give patient space to expand on a concern. Prompts will
cover the various dimensions of ‘acceptability’ including
content, complexity and comfort [24]. All staff will be in-
vited to give a similar acceptability rating for each element
and an overall score of the intervention. Free responses
will be analysed using a thematic framework approach. To
help prepare for a multi-centre randomised controlled
trial, participant recruitment and retention rates will be
calculated and a fidelity measure will be designed to evalu-
ate the extent to which the training delivery and imple-
mentation of the trained communication skills follows the
designed protocols.
Data management
Data from paper questionnaires will be anonymised by
replacing the participant’s name with a unique identifying
Table 1 Topics discussed during sessions of phase 1
Interview radiographers
Background about role
Staff experiences
Perceptions of patient experience
Improving communication
Feedback event radiographers
Validation of findings from interview
Distinguish between topics to be addressed ‘internally’ and for
co-design
Interview patients
Journey so far
Satisfaction with radiotherapy experience
Crucial points in radiotherapy process
Improving communication
Feedback event patients
Validation of findings presented in video
Mapping and rating of key stages and moments; agree on topics to
be discussed with staff
Joint staff-patient event
Exchange experiences (using video)
Determine shared priorities
Brainstorm to identify solutions
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code and saved in a password-protected database. Data
will be coded and entered into SPSS 24. Storage and
analysis will take place in a ‘safe haven’ at the University, a
room with secure entry procedures dedicated to analysing
audio-visual materials. The key with names and ID num-
bers will be stored in a secure location at the study site.
After audiotaped conversations are transcribed and coded,
all uniquely identifying information will be blanked out.
Data that is collected through the mobile phone applica-
tion will be visible for participants (via password-protected
access to the mobile application to guard against view by
third parties with access to the device) and sent to a
storage server in the ‘safe haven’ using Transport
Layer Security (version 3) when the participant’s
phone is connected to WIFI or mobile phone signal.
An AES 256-bit double-layer encryption system [25]
will be used to store the data.
Analyses
Audiotaped sessions from phases 1 and 2 will be tran-
scribed and content analysed [26], using a hybrid
strategy of inductive and deductive thematic analysis
[27]. Consultations that are audiotaped in phase 3 will
be analysed using the Verona coding definitions of
emotional sequences (VR-CoDES) [28], as described in
the FORECAST pilot study [17]. Latent variable
growth curve analysis (MPLUS) will be used to deter-
mine patients’ FCR trajectories and link these to FCR7
outcomes. Patient outcomes from the outlined study,
in which therapeutic radiographers have been exposed
to the communication skills training package, will be
compared to patient outcomes from the pilot study
that took place prior to the introduction of the train-
ing package. The cohort of the FORECAST pilot study
was drawn from the same institution; any differences
will be controlled for statistically in a conventional
method of covariate inclusion. Matching the sample
size of the pilot study cohort, the aim is to recruit 74
patients so that an effect of 0.375 (medium to low)
can be detected at 80% power with a two-sided alpha
of 0.05, to evaluate the effect of the training package
on FCR levels.
Fig. 2 Timeline of study enrolment and assessments of the evaluation phase (phase 3): after SPIRIT [34]
Table 2 Instruments used in evaluation of patient outcomes and psychometric properties
Instrument Measures Properties
FCR7 7-item self-report measure of patients’ Fear
of Cancer Recurrence
Internal consistency: Cronbach’s α of 0.92. Construct validity: r = 0.68
versus Anxiety Sub-scale of Hospital and Depression Scale [35]
FCR3 3-item self-report measure of patients’ Fear
of Cancer Recurrence
Based on the 4-item scale FCR4, with internal consistency:
Cronbach’s α of 0.93. Construct validity: r = 0.65 versus Anxiety
sub-scale of Hospital and Depression Scale [35]
PANAS 20-item self-report measure of Positive And
Negative Affect
Internal consistency: Cronbach’s α of 0.89 for Positive Affectivity;
0.85 for Negative Affectivity. Construct validity: r = 0.52 versus HADS
depression sub-scale; r = 0.67 versus Depression Anxiety and Stress
Scales (DASS) stress sub-scale and 0.65 versus HADS anxiety
sub-scale [36]
RISS 8-item self-report measure of patients’ Radiotherapy
Interview Satisfaction
Adapted from the Medical Interview Satisfaction Scale (MISS-21)
with internal consistency: 0.67–0.92 for sub-scales. Construct validity:
r = 0.21–0.63 versus aspects of satisfaction with consultations [37]
CARE 10-item self-report measure of patients’ experience
of Consultation and Relational Empathy
Internal consistency: Cronbach’s α of 0.92. Convergent validity:
r = 0.85 versus Reynolds Empathy Measure (RES) and sufficient
face validity [38]
EQ-5D-3L 5-item self-report measure of patients’ health status
relating to mobility, self-care, usual activities, pain and
discomfort, and anxiety and depression
Well-established reliability and validity; used in many countries
and for many different conditions [39, 40]
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Discussion
The outlined protocol describes the development of a com-
munication skills training package for therapeutic radiogra-
phers and an evaluation of its acceptability and feasibility in
a single centre. The findings of the FORECAST pilot study
indicate that patients’ review sessions with their radiogra-
phers during radiotherapy treatment may indeed be a good
moment to address patients’ concerns to minimise the
development of excessive recurrence fears [17]. The KEW
training package aims to support therapeutic radiographers
with recommendations and structured responses to con-
cerns expressed by patients.
Based on previous findings and a successful interven-
tion in the primary care setting [20], three facets of the
training programme will be to target patient knowledge,
to encourage patients to express their concerns and to
avoid cutoffs at the end of the conversation. In addition,
we will ask for participatory input from both patients
and therapeutic radiographers by making use of princi-
ples from the EBCD method and ask other patient
representatives and specialists in radiotherapy for con-
sultative feedback when developing the training package.
While there are some studies that have started to con-
sider communication skills training with members of the
radiotherapy team [29–31], none of these have involved
patients in the design process of the programme.
EBCD has proven to be helpful to encourage patient
engagement and obtain a more comprehensive consult-
ation [32]. At the same time, there are some challenges
that users of the method may encounter: the process can
be experienced as complicated, it can be difficult to get
staff engaged with the project and it is quite time-con-
suming [33]. It will therefore be essential to involve staff
from the onset of the study and communicate carefully
about expectations to all participants. Group sizes have
been decreased to shorten the duration of the sessions.
As there will only be one co-design event, it will also be
the key to encourage active engagement in this session
and to avoid it turning into ‘token participation’.
The study is expected to lead to new insights on how
to support radiographers with emotional conversations
and help patients manage their concerns about cancer
recurrence, and prepare us for a multi-centre roll-out
and randomised controlled trial to evaluate the resulting
communication package.
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